Betanis Myrbetriq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Betanis myrbetriq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Betanis Myrbetriq Today - Breaking & Trending Today

Astellas Pharma (OTCMKTS:ALPMY) Releases Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Astellas Pharma (OTCMKTS:ALPMY – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.09), MarketWatch Earnings reports. Astellas Pharma had a net margin of 6.27% and a return on equity of 12.77%. Astellas Pharma Stock Down 1.1 […] ....

United States , Betanis Myrbetriq , Astellas Pharma , Advagraf Graceptor , Astellas Pharma Inc , Astellas Pharma Company Profile , Get Free Report , Marketwatch Earnings , Pharma Stock Down , Pharma Inc , Astellas Pharma Daily , Otcmkts Alpmy ,

Astellas Pharma (OTCMKTS:ALPMY) Stock Price Passes Below Fifty Day Moving Average of $15.72

Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $15.72 and traded as low as $14.49. Astellas Pharma shares last traded at $14.55, with a volume of 144,614 shares. Analyst Ratings Changes Separately, […] ....

United States , Betanis Myrbetriq , Astellas Pharma , Advagraf Graceptor , Astellas Pharma Inc , Get Free Report , Pharma Inc , Astellas Pharma Daily , Otcmkts Alpmy ,

Short Interest in Astellas Pharma Inc. (OTCMKTS:ALPMY) Drops By 32.2%

Astellas Pharma Inc. (OTCMKTS:ALPMY – Free Report) was the recipient of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 40,900 shares, a drop of 32.2% from the May 31st total of 60,300 shares. Based on an average daily trading volume, of 89,800 shares, […] ....

United States , Advagraf Graceptor , Betanis Myrbetriq , Astellas Pharma , Astellas Pharma Inc , Free Report , Pharma Inc , Astellas Pharma Daily ,

Critical Contrast: Astellas Pharma (OTCMKTS:ALPMY) vs. Thorne HealthTech (NASDAQ:THRN)

Astellas Pharma (OTCMKTS:ALPMY – Get Rating) and Thorne HealthTech (NASDAQ:THRN – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Analyst Ratings This is a summary of recent recommendations and […] ....

New York , United States , Betanis Myrbetriq , Astellas Pharma , Thorne Healthtech , Harnal Omnic , Advagraf Graceptor , Minovia Therapeutics Ltd , Cytokinetics Incorporated , Thorne Healthtech Inc , Zenith Epigenetics Ltd , Cytomx Therapeutics Inc , Entertainment Inc , Merck Co Inc , Astellas Pharma Inc , Harvard University , Actinium Pharmaceuticals Inc , Thorne Healthtech Company Profile Get Rating , Astellas Pharma Company Profile Get Rating , Get Rating , Given Thorne Healthtech , Pharma Company Profile , Cytomx Therapeutics , Actinium Pharmaceuticals , Antibody Warhead Enabling , Zenith Epigenetics ,

Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Down 85.3% in May

Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 3,300 shares, a drop of 85.3% from the May 15th total of 22,400 shares. Based on an average daily volume of 136,900 shares, the […] ....

Betanis Myrbetriq , Astellas Pharma , Advagraf Graceptor , Jefferies Financial Group , Astellas Pharma Inc , Zacks Investment Research , Astellas Pharma Company Profile Get Rating , Get Rating , Financial Group , Pharma Company Profile , Pharma Inc , Otcmkts Alpmy ,